• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.在 PSA 时代,前列腺切除术后体重增加与前列腺癌复发的风险增加相关。
Cancer Prev Res (Phila). 2011 Apr;4(4):544-51. doi: 10.1158/1940-6207.CAPR-10-0257. Epub 2011 Feb 16.
2
Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy.接受根治性前列腺切除术的前列腺癌男性患者中,与肥胖和种族相关的病理变量及复发率。
J Clin Oncol. 2004 Feb 1;22(3):439-45. doi: 10.1200/JCO.2004.03.132. Epub 2003 Dec 22.
3
Obesity and long-term survival after radical prostatectomy.肥胖与根治性前列腺切除术的长期生存
J Urol. 2014 Oct;192(4):1100-4. doi: 10.1016/j.juro.2014.04.086. Epub 2014 Apr 21.
4
Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE.肥胖对根治性前列腺切除术后前列腺癌复发的影响:来自CaPSURE的数据。
Urology. 2005 Nov;66(5):1060-5. doi: 10.1016/j.urology.2005.05.040.
5
Obesity is not associated with aggressive pathologic features or biochemical recurrence after radical prostatectomy.肥胖与根治性前列腺切除术后侵袭性病理特征或生化复发无关。
Urology. 2013 May;81(5):992-6. doi: 10.1016/j.urology.2012.10.080. Epub 2013 Feb 28.
6
Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database.肥胖、前列腺特异性抗原最低值与根治性前列腺切除术后的生化复发:生物学因素还是技术因素?来自 SEARCH 数据库的结果。
Eur Urol. 2012 Nov;62(5):910-6. doi: 10.1016/j.eururo.2012.08.015. Epub 2012 Aug 20.
7
Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.肥胖与雄激素剥夺治疗后行根治性前列腺切除术的男性的去势抵抗性疾病和转移相关:来自 SEARCH 数据库的结果。
BJU Int. 2012 Aug;110(4):492-8. doi: 10.1111/j.1464-410X.2011.10754.x. Epub 2011 Nov 17.
8
The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.前列腺中油酸与硬脂酸的比例可预测局限性前列腺癌根治性前列腺切除术后的生化复发。
J Urol. 2007 Dec;178(6):2391-6; discussion 2396. doi: 10.1016/j.juro.2007.08.005. Epub 2007 Oct 22.
9
Obesity, risk of biochemical recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.肥胖与前列腺癌根治术后生化复发风险及前列腺特异抗原倍增时间的关系:来自 SEARCH 数据库的研究结果。
BJU Int. 2019 Jul;124(1):69-75. doi: 10.1111/bju.14594. Epub 2018 Nov 16.
10
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.根治性前列腺切除术后前列腺特异性抗原持续存在对预测淋巴结阳性前列腺癌患者临床进展和癌症特异性死亡率的作用。
Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.

引用本文的文献

1
Impact of Weight Management on Obesity-Driven Biomarkers of Prostate Cancer Progression.体重管理对肥胖驱动的前列腺癌进展生物标志物的影响。
J Urol. 2024 Apr;211(4):552-562. doi: 10.1097/JU.0000000000003849. Epub 2024 Feb 1.
2
Improving Whole Tomato Transformation for Prostate Health: Benign Prostate Hypertrophy as an Exploratory Model.改善番茄整体转化用于前列腺健康:良性前列腺增生作为探索模型。
Int J Mol Sci. 2023 Mar 17;24(6):5795. doi: 10.3390/ijms24065795.
3
Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications.前列腺癌中的脂代谢改变:多方面的肿瘤学意义。
Int J Mol Sci. 2023 Jan 11;24(2):1391. doi: 10.3390/ijms24021391.
4
White adipose tissue-derived factors and prostate cancer progression: mechanisms and targets for interventions.白色脂肪组织来源的因子与前列腺癌进展:干预的机制和靶点。
Cancer Metastasis Rev. 2022 Sep;41(3):649-671. doi: 10.1007/s10555-022-10056-0. Epub 2022 Aug 4.
5
Association between baseline body mass index and survival in men with metastatic hormone-sensitive prostate cancer: ECOG-ACRIN CHAARTED E3805.基线身体质量指数与转移性激素敏感前列腺癌男性患者生存的相关性:ECOG-ACRIN CHAARTED E3805。
Prostate. 2022 Sep;82(12):1176-1185. doi: 10.1002/pros.24369. Epub 2022 May 10.
6
Twelve unanswered questions in cancer inspired by the life and work of Leland Chung: "if this is true, what does it imply"?受利兰·钟的生平与工作启发的癌症领域的十二个未解答问题:“如果这是真的,这意味着什么?”
Am J Clin Exp Urol. 2021 Aug 25;9(4):254-260. eCollection 2021.
7
Using Exercise and Nutrition to Alter Fat and Lean Mass in Men with Prostate Cancer Receiving Androgen Deprivation Therapy: A Narrative Review.运用运动和营养干预来改变接受雄激素剥夺治疗的前列腺癌男性的体脂和去脂体重:一篇叙述性综述。
Nutrients. 2021 May 14;13(5):1664. doi: 10.3390/nu13051664.
8
Exploration of biomarkers from a pilot weight management study for men undergoing radical prostatectomy.男性根治性前列腺切除术患者体重管理研究的生物标志物探索。
Urol Oncol. 2021 Aug;39(8):495.e7-495.e15. doi: 10.1016/j.urolonc.2021.01.010. Epub 2021 Feb 7.
9
Obesity is Associated with Shorter Telomere Length in Prostate Stromal Cells in Men with Aggressive Prostate Cancer.肥胖与侵袭性前列腺癌患者前列腺基质细胞端粒长度缩短相关。
Cancer Prev Res (Phila). 2021 Apr;14(4):463-470. doi: 10.1158/1940-6207.CAPR-20-0250. Epub 2020 Dec 22.
10
Feasibility of a Weight Management Program Tailored for Overweight Men with Localized Prostate Cancer - A Pilot Study.针对局部前列腺癌超重男性的体重管理计划的可行性 - 一项试点研究。
Nutr Cancer. 2021;73(11-12):2671-2686. doi: 10.1080/01635581.2020.1856890. Epub 2020 Dec 9.

本文引用的文献

1
Implications of body mass index in Japanese patients with prostate cancer who had undergone radical prostatectomy.体重指数对接受根治性前列腺切除术的日本前列腺癌患者的影响。
Jpn J Clin Oncol. 2010 Apr;40(4):353-9. doi: 10.1093/jjco/hyp164. Epub 2010 Jan 10.
2
A prospective study of lifetime physical activity and prostate cancer incidence and mortality.一项关于终生身体活动与前列腺癌发病率和死亡率的前瞻性研究。
Br J Cancer. 2009 Dec 1;101(11):1932-8. doi: 10.1038/sj.bjc.6605404. Epub 2009 Oct 27.
3
Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort.多民族队列中体重、身高和体重增加与前列腺癌风险的关系。
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2413-21. doi: 10.1158/1055-9965.EPI-09-0293. Epub 2009 Sep 1.
4
Age-specific physical activity and prostate cancer risk among white men and black men.白人男性和黑人男性中特定年龄的身体活动与前列腺癌风险
Cancer. 2009 Nov 1;115(21):5060-70. doi: 10.1002/cncr.24538.
5
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.体重指数和前列腺特异性抗原作为前列腺切除术后不良病理和生化复发的预测指标。
J Urol. 2009 Aug;182(2):491-6; discussion 496-8. doi: 10.1016/j.juro.2009.04.007. Epub 2009 Jun 13.
6
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapy.体质指数不是荷兰接受近距离放射治疗的男性患者前列腺特异性抗原失败和生存的预后标志物。
BJU Int. 2010 Jan;105(1):42-8. doi: 10.1111/j.1464-410X.2009.08687.x. Epub 2009 Jun 10.
7
Physical activity and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.欧洲癌症与营养前瞻性调查(EPIC)队列研究中的体育活动与前列腺癌风险
Int J Cancer. 2009 Aug 15;125(4):902-8. doi: 10.1002/ijc.24326.
8
Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.体重指数作为荷兰接受根治性前列腺切除术男性生化复发的预后标志物。
BJU Int. 2009 Aug;104(3):321-5. doi: 10.1111/j.1464-410X.2009.08404.x. Epub 2009 Feb 11.
9
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy.前列腺切除术后接受挽救性放疗患者的肥胖与生化失败风险
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1017-22. doi: 10.1016/j.ijrobp.2008.05.041. Epub 2008 Aug 15.
10
Body mass index trends and role of obesity in predicting outcome after radical prostatectomy.体重指数趋势及肥胖在预测根治性前列腺切除术后结局中的作用。
Urology. 2008 Nov;72(5):1106-10. doi: 10.1016/j.urology.2008.04.021. Epub 2008 Jul 7.

在 PSA 时代,前列腺切除术后体重增加与前列腺癌复发的风险增加相关。

Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.

机构信息

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe Street, Rm. E6137, Baltimore, MD 21205, USA.

出版信息

Cancer Prev Res (Phila). 2011 Apr;4(4):544-51. doi: 10.1158/1940-6207.CAPR-10-0257. Epub 2011 Feb 16.

DOI:10.1158/1940-6207.CAPR-10-0257
PMID:21325564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3072036/
Abstract

Although obesity at the time of prostatectomy has been associated with prostate cancer recurrence, it is unknown whether obesity before or after surgery, or weight change from the years prior to surgery to after surgery is associated with recurrence. Thus, we examined the influence of obesity and weight change on recurrence after prostatectomy. We conducted a retrospective cohort study of 1,337 men with clinically localized prostate cancer who underwent prostatectomy performed during 1993-2006 by the same surgeon. Men self-reported weight and physical activity at 5 years before and 1 year after surgery on a survey during follow-up. Mean follow-up was 7.3 years. We estimated multivariable-adjusted HRs of prostate cancer recurrence comparing obesity at 5 years before and at 1 year after surgery with normal weight, and a gain of more than 2.2 kg from 5 years before to 1 year after surgery with stable weight. During 9,797 person years of follow-up, 102 men recurred. Compared with men who had stable weight, those whose weight increased by more than 2.2 kg had twice the recurrence risk (HR = 1.94; 95% CI, 1.14-3.32) after taking into account age, pathologic stage and grade, and other characteristics. The HR of recurrence was 1.20 (95% CI, 0.64-2.23) and 1.72 (95% CI, 0.94-3.14) comparing obesity at 5 years before and at 1 year after surgery, respectively, with normal weight. Physical activity (≥ 5 h/wk) did not attenuate risk in men who gained more than 2.2 kg. By avoiding weight gain, men with prostate cancer may both prevent recurrence and improve overall well-being.

摘要

尽管前列腺切除术时的肥胖与前列腺癌复发有关,但尚不清楚肥胖是在手术前还是手术后,或者是从手术前几年到手术后体重的变化与复发有关。因此,我们研究了肥胖和体重变化对前列腺切除术后复发的影响。我们对 1993 年至 2006 年间由同一位外科医生进行前列腺切除术的 1337 名局限性前列腺癌男性进行了回顾性队列研究。在随访期间的一项调查中,男性自我报告了手术前 5 年和手术后 1 年的体重和身体活动情况。平均随访时间为 7.3 年。我们比较了手术前 5 年和手术后 1 年的肥胖与正常体重,以及从手术前 5 年到手术后 1 年体重增加超过 2.2 公斤与体重稳定的肥胖与正常体重的多变量调整后的 HR。在 9797 人年的随访期间,有 102 名男性复发。与体重稳定的男性相比,体重增加超过 2.2 公斤的男性复发风险增加了一倍(HR = 1.94;95%CI,1.14-3.32),同时考虑了年龄、病理分期和分级以及其他特征。与正常体重相比,手术前 5 年肥胖的 HR 为 1.20(95%CI,0.64-2.23),手术后 1 年肥胖的 HR 为 1.72(95%CI,0.94-3.14)。与正常体重相比,手术前 5 年肥胖和手术后 1 年肥胖的 HR 分别为 1.20(95%CI,0.64-2.23)和 1.72(95%CI,0.94-3.14)。对于体重增加超过 2.2 公斤的男性,体力活动(≥ 5 小时/周)并没有降低风险。通过避免体重增加,前列腺癌患者既可以预防复发,又可以改善整体健康状况。